3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Classical hematology
1
Conditions
Neoplasms
6
Breast Neoplasms
4
Prostatic Neoplasms
3
Lung Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Disease
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Parkinson Disease
1
Osteosarcoma
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Histologically-confirmed Malignancies
1
Hepatic Malignancies
1
Hematologic Neoplasms
1
Glioma
1
Glioblastoma
1
Febrile Neutropenia
1
Esophageal Neoplasms
1
Carcinoma, Neuroendocrine
1
Carcinoma, Hepatocellular
1
Interventions
Cyclophosphamide
22
fludarabine phosphate
17
Cyclosporine
15
Peripheral Blood Stem Cell Transplantation
14
Methotrexate
14
Filgrastim
14
Whole-Body Irradiation
11
Mycophenolic Acid
11
Busulfan
11
Antilymphocyte Serum
11
Radiotherapy
8
Melphalan
8
Exercise
8
Dexamethasone
8
Cytarabine
8
Asparaginase
8
venetoclax
7
blinatumomab
7
Vincristine
7
Etoposide
7
Daunorubicin
7
fludarabine
6
Methylprednisolone
6
Mercaptopurine
6
Granulocyte Colony-Stimulating Factor
6
Therapeutics
5
Psychiatric Rehabilitation
5
Prednisone
4
Immunotherapy, Adoptive
4
Cord Blood Stem Cell Transplantation
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Positron Emission Tomography Computed Tomography
×
Clear all
NCT03429387
2022-05-17
PIPPIN
Peter MacCallum Cancer Centre, Australia
Phase NA
Completed
147 enrolled